… ProQR to Present at Upcoming Scientific Meeting and Investor … at 9:30am EST, Daniel de Boer, Chief Executive Officer of ProQR, will present at the LEERINK 7 th Annual Global … be accessible from the ‘Investor Relations’ section of ProQR’s website ( www.proqr.com ) under ‘Events and …
… ProQR Announces Financial Results for the Third Quarter of … LCA10,” said Daniel A. de Boer, chief executive officer of ProQR. “These results build confidence in QR-110 and the … for QR-110 in patients with LCA10 and preclinical data for ProQR’s Axiomer ® RNA-editing technology. Abstract titles: …
… ProQR Announces Financial Results for the Second Quarter of … said Daniel A. de Boer, chief executive officer of ProQR. “Over the next twelve months, we are looking forward … current cash on hand of €33.0 million (at June 30, 2018), ProQR’s operation is funded into late 2019 Subsequent Events …
… ProQR to Present at the Annual Piper Jaffray Healthcare … be accessible from the ‘Investor Relations’ section of ProQR’s website ( www.proqr.com ) under ‘Events and Presentations’. The …
LEIDEN, the Netherlands, May 15, 2017 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), remembers co-founder and supervisory board member Henri A. Termeer, who unexpectedly passed away Friday May 12, 2017 at age 71 at his house in Marblehead, MA.
… ProQR Announces Financial Results for the First Quarter of … retinal diseases,” said Daniel A. de Boer, CEO of ProQR. “We expect 2019 to be a transformative year for ProQR … for the same period last year. Research and development (R&D) costs increased to €12.0 million for the quarter ended …
LEIDEN, the Netherlands, April 20, 2017 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR) today announced that Gerard Platenburg, Chief Innovation Officer, will present at the 42nd Annual Deutsche Bank Health Care Conference on Wednesday, May 3, 2017 at 12:50pm ET.